Switch theme
Sign up to access all valuation multiples
4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.
2012
145
LTM Revenue $4.1M
LTM EBITDA -$18.9M
$92.9M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
4DMedical has a last 12-month revenue of $4.1M and a last 12-month EBITDA of -$18.9M.
In the most recent fiscal year, 4DMedical achieved revenue of $1.9M and an EBITDA of -$20.1M.
4DMedical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See 4DMedical valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $0.2M | $1.9M | XXX | XXX | XXX |
| Gross Profit | $0.2M | $0.2M | XXX | XXX | XXX |
| Gross Margin | 99% | 8% | XXX | XXX | XXX |
| EBITDA | -$18.1M | -$20.1M | XXX | XXX | XXX |
| EBITDA Margin | -10123% | -1045% | XXX | XXX | XXX |
| Net Profit | -$15.6M | -$19.9M | XXX | XXX | XXX |
| Net Margin | -8715% | -1032% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of March 14, 2025, 4DMedical's stock price is AUD 0 (or $0).
4DMedical has current market cap of AUD 158M (or $99.9M), and EV of AUD 147M (or $92.9M).
See 4DMedical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $92.9M | $99.9M | XXX | XXX | XXX | XXX | $-0.05 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of March 14, 2025, 4DMedical has market cap of $99.9M and EV of $92.9M.
4DMedical's trades at 22.5x LTM EV/Revenue multiple, and -4.9x LTM EBITDA.
Analysts estimate 4DMedical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for 4DMedical and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $92.9M | XXX | XXX | XXX |
| EV/Revenue | 27.4x | XXX | XXX | XXX |
| EV/EBITDA | -4.8x | XXX | XXX | XXX |
| P/E | -4.5x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -4.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign Up4DMedical's NTM/LTM revenue growth is 156%
4DMedical's revenue per employee for the last fiscal year averaged $13K, while opex per employee averaged $0.2M for the same period.
Over next 12 months, 4DMedical's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate 4DMedical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for 4DMedical and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 981% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -574% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -418% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $13K | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 46% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 943% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 23% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 1621% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
4DMedical acquired XXX companies to date.
Last acquisition by 4DMedical was XXXXXXXX, XXXXX XXXXX XXXXXX . 4DMedical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was 4DMedical founded? | 4DMedical was founded in 2012. |
| Where is 4DMedical headquartered? | 4DMedical is headquartered in Australia. |
| How many employees does 4DMedical have? | As of today, 4DMedical has 145 employees. |
| Is 4DMedical publicy listed? | Yes, 4DMedical is a public company listed on ASX. |
| What is the stock symbol of 4DMedical? | 4DMedical trades under 4DX ticker. |
| When did 4DMedical go public? | 4DMedical went public in 2020. |
| Who are competitors of 4DMedical? | Similar companies to 4DMedical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of 4DMedical? | 4DMedical's current market cap is $99.9M |
| What is the current revenue of 4DMedical? | 4DMedical's last 12-month revenue is $4.1M. |
| What is the current EBITDA of 4DMedical? | 4DMedical's last 12-month EBITDA is -$18.9M. |
| What is the current EV/Revenue multiple of 4DMedical? | Current revenue multiple of 4DMedical is 22.5x. |
| What is the current EV/EBITDA multiple of 4DMedical? | Current EBITDA multiple of 4DMedical is -4.9x. |
| What is the current revenue growth of 4DMedical? | 4DMedical revenue growth between 2023 and 2024 was 981%. |
| Is 4DMedical profitable? | Yes, 4DMedical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
